| Parameter | RA Patients | Healthy subjects | p value |
| Disease Characteristics |
|
|
|
| Disease duration, mean ± SD, years | 9 ± 7 | / | / |
| Disease activity score, n (%) |
|
|
|
| · HAD, n (%) | 3 (9.7%) | / | / |
| · MDA, n (%) | 15 (48.4%) | / | / |
| · LDA, n (%) | 5 (26.1%) | / | / |
| · Remission, n (%) | 8 (25.8%) | / | / |
| Medications |
|
|
|
| · Corticosteoid, n (%) | 20 (70.9%) | / | / |
| · Methotrexate, n (%) | 19 (61.3%) | / | / |
| · Hydroxychloroquinone, n (%) | 14 (45.2%) | / | / |
| · NSAID, n (%) | 4 (12.9%) | / | / |
| · Sulfasalazine, n (%) | 2 (6.5%) | / | / |
| · No medications, n (%) | 3 (9.7%) | / | / |
| Anthroprometric parameters |
|
|
|
| BMI, mean ± SD, kg/m2 | 28.0 ± 4.8 | 25.2 ± 3.7 | p = 0.05 |
| Abdominal circumference, mean ± SD, cm | 95.6 ± 10.5 | 88.6 ± 9.7 | p = 0.07 |
| Cardiovascular risk factors |
|
|
|
| Smoking, n (%) | 0 | 0 | / |
| Alcohol consumption, n (%) | 15 (48.4%) | 22 (68.8%) | 0.10 |
| Family history of CVD, n (%) | 17 (54.4%) | 14 (43.8%) | 0.40 |
| Abdominal obesity, n (%) | 20 (64.5%) | 11 (34.4%) | 0.02 |
| Physical activity, n (%) | 10 (32.3%) | 17 (53.1%) | 0.10 |
| BMI ≥ 25 kg/m2, n (%) | 20 (64.5%) | 11 (34.4%) | 0.02 |
| Hypertension, n (%) | 5 (16.1%) | 1 (3.1%) | 0.02 |
| Dyslipidemia, n (%) | 0 | 0 | / |